Showing results (11-20 of 78) with videos related to

Sort By:
Pageof 8
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1991
Regimen-related toxicity of a busulfan-cyclophosphamide conditioning regimen in 70 patients undergoing allogeneic bone marrow transplantationT J Nevill, M J Barnett, H G Klingemann, et al.
Bone Marrow Transplantation|November 1, 1992
Treatment of myelodysplastic syndrome with busulfan-cyclophosphamide conditioning followed by allogeneic BMTT J Nevill, J D Shepherd, D E Reece, et al.
Leukemia & Lymphoma|September 7, 2000
Development of a biologically distinct EBV-related lymphoproliferative disorder following autologous bone marrow transplantation for an EBV-negative post-renal allograft Burkitt's lymphomaC A Lohrisch, T J Nevill, M J Barnett, et al.
American Journal of Hematology|January 6, 2023
A young woman with persistent sore throat, Epstein-Barr virus, lymphadenopathy, and aberrant CD4 + CD7- T-cellsMariam Goubran, Eric McGinnis, Ryan J Stubbins, et al.
Bone Marrow Transplantation|October 6, 2000
Effect of gastrointestinal inflammation and age on the pharmacokinetics of oral microemulsion cyclosporin A in the first month after bone marrow transplantationK R Schultz, T J Nevill, R F Balshaw, et al.
Bone Marrow Transplantation|May 1, 1992
Influence of post-methotrexate folinic acid rescue on regimen-related toxicity and graft-versus-host disease after allogeneic bone marrow transplantationT J Nevill, M H Tirgan, H J Deeg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1991
Busulfan, cyclophosphamide, and melphalan conditioning for autologous bone marrow transplantation in hematologic malignancyG L Phillips, J D Shepherd, M J Barnett, et al.
Haematologica|August 30, 2012
Correlation of clinical response and response duration with miR-145 induction by lenalidomide in CD34(+) cells from patients with del(5q) myelodysplastic syndromeChristopher P Venner, Joanna Wegrzyn Woltosz, Thomas J Nevill, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 27, 2012
Normal karyotype CALLA-positive adult pre-B ALL: dismal outcome with chemotherapy for patients with loss/gain of ABL1 and/or BCR FISH signalsYasser R Abou Mourad, Rahul Bhargava, Hélène Bruyère, et al.
British Journal of Cancer|September 1, 1993
High-dose chemotherapy and autologous bone marrow transplantation for patients with poor prognosis nonseminomatous germ cell tumoursM J Barnett, C M Coppin, N Murray, et al.
Pageof 8